When the fingers do the talking: A study of group participation for different kinds of shareable surfaces

and other research outputs When the fingers do the talking: A study of group par-ticipation for different kinds of shareable surface

Pruritus is a common feature in sheep infected with the BSE agent.

BACKGROUND: The variability in the clinical or pathological presentation of transmissible spongiform encephalopathies (TSEs) in sheep, such as scrapie and bovine spongiform encephalopathy (BSE), has been attributed to prion protein genotype, strain, breed, clinical duration, dose, route and type of inoculum and the age at infection. The study aimed to describe the clinical signs in sheep infected with the BSE agent throughout its clinical course to determine whether the clinical signs were as variable as described for classical scrapie in sheep. The clinical signs were compared to BSE-negative sheep to assess if disease-specific clinical markers exist. RESULTS: Forty-seven (34%) of 139 sheep, which comprised 123 challenged sheep and 16 undosed controls, were positive for BSE. Affected sheep belonged to five different breeds and three different genotypes (ARQ/ARQ, VRQ/VRQ and AHQ/AHQ). None of the controls or BSE exposed sheep with ARR alleles were positive. Pruritus was present in 41 (87%) BSE positive sheep; the remaining six were judged to be pre-clinically infected. Testing of the response to scratching along the dorsum of a sheep proved to be a good indicator of clinical disease with a test sensitivity of 85% and specificity of 98% and usually coincided with weight loss. Clinical signs that were displayed significantly earlier in BSE positive cases compared to negative cases were behavioural changes, pruritic behaviour, a positive scratch test, alopecia, skin lesions, teeth grinding, tremor, ataxia, loss of weight and loss of body condition. The frequency and severity of each specific clinical sign usually increased with the progression of disease over a period of 16-20 weeks. CONCLUSION: Our results suggest that BSE in sheep presents with relatively uniform clinical signs, with pruritus of increased severity and abnormalities in behaviour or movement as the disease progressed. Based on the studied sheep, these clinical features appear to be independent of breed, affected genotype, dose, route of inoculation and whether BSE was passed into sheep from cattle or from other sheep, suggesting that the clinical phenotype of BSE is influenced by the TSE strain more than by other factors. The clinical phenotype of BSE in the genotypes and breed studied was indistinguishable from that described for classical scrapie cases

"Pharmacology of salicin derivatives in sheep" : a thesis presented in partial fulfilment of the requirements for the degree of Doctor of Philosophy in Animal Science, Institute of Veterinary, Animal and Biomedical Sciences, Massey University, Palmerston North, New Zealand

Content removed from thesis due to copyright reasons: Figure 1.20(e). S. viminalis. Retrieved from Valerie J.:http://gardeners-word.blogspot.co.uk/Sheep suffer from pain during various husbandry practices as well as during injury or diseases such as footrot. This pain could be potentially minimised with the use of analgesics such as non-steroidal anti-inflammatory drugs (NSAID). Unfortunately, there are very few registered NSAIDs for sheep. Thus, registered analgesics for cattle, for instance ketoprofen and meloxicam are used in sheep. Again, the high cost of analgesics and associated potential side effects such as reduced fertility, gastric irritation, gastric ulcers etc. evident in other species usually limits their use in sheep. Fear of residues in meat may stop some farmers from using analgesics. Considering these problems, this study was designed as a groundwork to explore a possible and potential use of natural, inexpensive analgesic for sheep. Salicylic acid, a derivative of salicin, is a NSAID used effectively in humans as an analgesic since ancient times in the form of willow bark and leaves. During this research study, the pharmacokinetics of salicylic acid in sheep was analysed after administration of the sodium salt of salicylic acid (sodium salicylate/NaS) intravenously and orally at different dose rates. The analgesic efficacy of salicylic acid in sheep was also studied after administration of sodium salicylate at different dose rates by measuring mechanical and thermal nociceptive thresholds. The minimum therapeutic plasma concentration of salicylic acid for analgesia in sheep ranged from 25 to 30 μg/mL, which was achieved for about 30 minutes by a 200 mg/kg intravenous dose of NaS. During this study it was discovered that thermal nociceptive threshold testing is unable to detect any analgesia from salicylic acid and ketoprofen in sheep. However, mechanical nociceptive threshold testing efficiently detected the analgesic effects of salicylic acid and the positive control, ketoprofen. The seasonal variation of willow salicin content (principal precursor of salicylic acid in willow) was studied over a year. The salicin in willows in New Zealand is higher during the summer months as compared to the winter months of the year, and appears greater in areas subject to drought. The analgesic efficacy of willow leaves can be assessed by feeding the willow leaves to lame sheep as they readily eat willow leaves. However, to assess the analgesia produced by willow in sheep, further research is warranted. Keywords: Salicin, sheep, salicylic acid, analgesia, HPLC, nociceptive testing, willow

Internal parasites and association with diarrhoea in sheep at an abattoir in Western Australia

Diarrhoea (scouring) is an important issue for the sheep meat industry. Scouring is a major risk factor for fleece soiling and consequential carcase contamination with microbes that cause meat spoilage and potential dangers for humans (2). There is little information on the causes of scouring in sheep at slaughter. Strongyle worm infections are commonly implicated in scouring and reduced production, yet there is no published data quantifying strongyle infections in scouring and normal sheep at abattoirs. In addition, Giardia and Cryptosporidium have been associated with scouring in ruminants, but little is known about the prevalence, genotypes present or the effect on production in sheep populations. This study carried out at an abattoir in Western Australia (WA), aimed to investigate the extent of strongyle, Giardia and Cryptosporidium infections and any association with scouring in sheep

Secondary cytotoxicity of (crosslinked) dermal sheep collagen during repeated exposure to human fibroblasts

We investigated commercially available dermal sheep collagen either cross-linked with hexamethylenediisocyanate, or cross-linked with glutaraldehyde. In previous in vitro studies we could discriminate primary, i.e. extractable, and secondary cytotoxicity, due to cell-biomaterial interactions, i.e. enzymatic actions. To develop dermal sheep collagen for clinical applications, we focused in this study on the release, e.g. elimination, of secondary cytotoxicity over time. We used the universal 7 d methylcellulose cell culture with human skin fibroblasts as a test system. Hexamethylenediisocyanate-cross-linked dermal sheep collagen and glutaraldehyde-cross-linked dermal sheep collagen were tested, with intervals of 6 d, over a culture period of 42 d. With hexamethylenediisocyanate-cross-linked dermal sheep collagen, cytotoxicity, i.e. cell growth inhibition and deviant cell morphology, was eliminated after 18 d of exposure. When testing glutaraldehyde-cross-linked dermal sheep collagen, the bulk of cytotoxic products was released after 6 d, but a continuous low secondary cytotoxicity was measured up to 42 d. As a control, non-cross-linked dermal-sheep collagen was tested over a period of 36 d, but no secondary cytotoxic effects were observed. The differences in release of secondary cytotoxicity between hexamethylenediisocyanate-cross-linked dermal sheep collagen, glutaraldehyde-cross-linked dermal sheep collagen and non-cross-linked dermal sheep collagen are explained from differences in cross-linking agents and cross-links obtained. We hypothesize that secondary cytotoxicity results from enzymatic release of pendant molecules from hexamethylene-diisocyanate-cross-linked dermal sheep collagen, e.g. formed after reaction of hydrolysis products of hexamethylenediisocyanate with dermal sheep collagen. Glutaraldehyde-cross-linked dermal sheep collagen contains residual cross-linking agents, which induce the bulk cytotoxicity. Apart from being sensitive to enzymatic degradation, glutaraldehyde-cross-linked dermal sheep collagen was also found to be sensitive to aqueous hydrolysis. Hydrolysis of cross-links may release cytotoxic products and introduce new pendant molecules within glutaraldehyde-cross-linked dermal sheep collagen, which in turn induce cytotoxicity after enzymatic attack

Seizure Disorders in Goats and Sheep.

BackgroundGoats and sheep are more likely to be presented for examination for seizures than are cattle, possibly as a consequence of their relatively smaller body size. Currently, no reports describing seizure disorders in goats and sheep are available.ObjectivesTo describe clinical features and treatment outcomes of sheep and goats presented for seizures.AnimalsA total of 59 goats and 21 sheep presented for seizures.MethodsRetrospective study. Medical records from 1994 to 2014 at the Veterinary Medical Teaching Hospital, University of California, Davis, were reviewed. Descriptive statistics were used to summarize data. Logistic regression was performed to determine whether variables were associated with mortality.ResultsThe majority of seizures in goats and sheep had structural or metabolic causes. Polioencephalomalacia (PEM) secondary to ruminal lactic acidosis or PEM of undetermined cause was the most frequently diagnosed cause of seizures in goats and sheep. The proportions of mortality in goats and sheep were 49.2 and 42.9%, respectively. Age increased the odds mortality (odds ratio [OR], 1.51; 95% confidence interval [CI], 1.07, 2.14) in goats. Goats with structural or metabolic causes of seizures had higher odds for mortality (OR, 37.48; 95% CI, 1.12, 99.10) than those with unknown causes. Age and etiological diagnosis were not significant (P > .05) predictors of mortality in affected sheep.Conclusions and clinical relevanceSeizure disorders in goats and sheep are associated with high mortality, despite treatment. Current treatment in goats and sheep with seizures warrants further investigation to determine whether treatments are beneficial or detrimental to survival

Effects of Ostertagia circumcincta larvae and adult parasites on abomasal and intestinal tissues in sheep : a thesis presented in partial fulfilment of the requirements for the degree of Master of Science in Physiology

Ostertagia circumcincta parasites infect the abomasum of sheep causing damage to the abomasal tissues and significant production losses to the sheep farming industry. Ingested larvae enter the gastric glands and emerge as adults which live in the abomasal lumen. The effect of adult parasites on the abomasum has not been systematically investigated. In the present study, sheep raised to be free of helminth parasites were given either adult O. circumcincta parasites via an abomasal cannula or larvae per os. Adult as well as larval O. circumcincta parasites stimulate hypergastrinaemia, a decreased abomasal pH and elevated serum pepsinogen concentrations. While the concentration of G cells did not change in the larval parasite infected sheep compared with the non-infected control sheep, the total number of G cells was increased due to an increase in mucosal thickness. There appeared to be fewer G cells present in the adult parasite infected sheep compared with the non-infected control sheep, which was most likely due to a depletion of their gastrin content due to overstimulation. The hypergastrinaemia observed during ostertagiasis is not due to a change in the ratio of G:D cells. The lumen dwelling adult O. circumcincta affect the mucosa of the abomasum resulting in an apparent inflammatory reaction, demonstrated by the presence of eosinophils and neutrophils in the lamina propria. Mucous production and/or secretion is also affected, shown by the presence of large mucus-secreting cells in the mucosa. The total wet weight of the abomasum/kg body weight is increased in sheep infected with O. circumcincta, with an increase in the total size of the abomasum. The larval parasites evoke a hyperplasia in both the antral and body mucosae with little change in cell size. In sheep infected with adult parasites, the thickness of the abomasal mucosa is increased in the body, but not the antrum. This increase is most likely due to hypertrophy. Either the larval O. circumcincta or the hypergastrinaemia have trophic effects on the upper duodenum, with an increased mucosal thickness which did not occur more distally. This did not occur in the adult parasite infected sheep. The larval parasites or hypergastrinaemia provoked a hyperplasia in the jejunal mucosa. This did not occur in the adult infected sheep. The larvae and adult parasites did not appear to exert a hypertrophic or hyperplastic effect on the ileum, caecum or colon. Those results indicate that adult O. circumcincta parasites have substantial effects on the ovine abomasum